International Branding Executive Ashleigh Vogstad Joining Redfund Capital

Millennial Marketeer Bolsters Board of Directors

Millennial Marketeer Bolsters Board of Directors


Vancouver, British Columbia, October 10th, 2019 – Redfund Capital Corp. (CSE: LOAN) (Frankfurt:O3X4) (OTC: PNNRF) (Redfund Capital or the “Company”) is pleased to announce Ashleigh Vogstad, an international marketing and branding trailblazer to the board of directors of the Company.

Ashleigh is the founder and CEO of Transcends, a marketing agency that excels in branding and facilitates partnerships for technology companies and their global vendors like Microsoft. Her previous roles have included being President for a $100m FMCG company in the US, owner of a Canadian hospitality concept, partner in a VC firm investing in biotech, and sitting on several charitable boards, including running marketing and crisis management for His Holiness, The Dalai Lama during his Canadian tour.

“We could not be more fortunate to bring an amazing woman and millennial to the board. Ashleigh commutes between Seattle and Auckland and her international reach is something that will enhance all our new projects. Branding our own health and wellness products and those of our portfolio clients will be a win-win for everyone,” stated Meris Kott, CEO, “It is rare to have three woman on a public company board and it is a hope of mine that more companies follow our lead.”

About Redfund Capital Corp.

Redfund partners with first mover, high growth companies, and provides them with access to capital, resources, and infrastructure. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

For further information please visit

For more information on Redfund Capital Corp. contact

Meris Kott CEO 604.484.8989
0r [email protected]

Further information about the Company is available on under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.



NOVEMBER 17, 2022

Global Wellness Strategies Forms Pharma Subsidiary

Focused on Clinical Trials